Neuroimaging in drug abuse

被引:10
作者
Kimberly P. Lindsey
S. John Gatley
Nora D. Volkow
机构
[1] Brookhaven National Laboratory,Medical Department
关键词
Positron Emission Tomography; Cocaine; Methylphenidate; Dopamine Transporter; Raclopride;
D O I
10.1007/s11920-003-0068-3
中图分类号
学科分类号
摘要
Neuroimaging techniques, including positron emission tomography (PET), are ideally suited for studies of addiction. These minimally invasive modalities yield information about acute and long-term drug-induced structural and functional changes in the brain over time. Changes can be observed in the brains of human and animal subjects during drug self-administration. Neuroimaging with PET allows precise quantification and visualization of the drug and its rates of movement in the body. In addition, imaging reveals recovery of function and reappearance of neuronal markers in abstinent drug users. Evidence that suggests that PET may have use in identifying individuals predisposed to become addicted is emerging. Finally, candidate pharmacotherapies for drug addiction can be critically evaluated. These unique assets clearly point to the use of these strategies for addiction studies.
引用
收藏
页码:355 / 361
页数:6
相关论文
共 150 条
[1]  
Wise RA(1989)Brain dopamine and reward Annu Rev Psychol 40 191-225
[2]  
Rompre PP(1995)The dopamine transporter: immunochemical characterization and localization in brain J Neurosci 15 1714-1723
[3]  
Ciliax BJ(1992)Neurotoxic amphetamine analogues: effects in monkeys and implications for humans Ann N Y Acad Sci 648 371-382
[4]  
Heilman C(1998)Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations J Neurosci 18 419-427
[5]  
Demchyshyn LL(1998)Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428 J Neurosci 18 8417-8422
[6]  
Ricaurte GA(1996)Striatal dopamine nerve terminal markers in human, chronic methamphetamine users Nat Med 2 699-703
[7]  
McCann UD(1990)Effects of chronic cocaine abuse on postsynaptic dopamine receptors Am J Psychiatry 147 719-724
[8]  
Villemagne V(1997)Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects Nature 386 830-833
[9]  
Yuan J(1997)Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal Neuropsychopharmacology 16 174-182
[10]  
Wong DF(1996)Decreases in dopamine receptors but not in dopamine transporters in alcoholics Alcohol Clin Exp Res 20 1594-1598